Cardiol Therapeutics (CRDL) Capital Expenditures (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Capital Expenditures came in at -$34699.3 in Q1 2026, down 317.03% YoY from $15987.9 in Q1 2025, and down 205.47% on a QoQ basis from $32899.9 in Q4 2025.
Cardiol Therapeutics (CRDL) Capital Expenditures (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Capital Expenditures data on file, last reported at -$34699.3 in Q1 2026.
- Quarterly Capital Expenditures fell 317.03% year-over-year to -$34699.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8639.4 (down 193.87% YoY) and the FY2025 annual result came in at $17557.1, up 15.2% from the prior year.
- Capital Expenditures retreated to -$34699.3 in Q1 2026, from $32899.9 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $86615.0 in Q4 2023 to a low of -$34699.3 in Q1 2026.
- A 5-year average of $5808.7 and a median of -$2896.7 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 265.19% — and 2026, when it sank 317.03%.
- Tracing CRDL's Capital Expenditures over 5 years: stood at $74840.2 in 2022, then increased by 15.73% to $86615.0 in 2023, then slumped by 69.9% to $26071.9 in 2024, then advanced by 26.19% to $32899.9 in 2025, then plunged by 205.47% to -$34699.3 in 2026.
- The last three Capital Expenditures figures came in at -$34699.3 (Q1 2026), $32899.9 (Q4 2025), and -$2193.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - | -2,189.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,699.25 |
| Mar 31, 2026 | -34,699.25 |
| Dec 31, 2025 | 32,899.92 |
| Dec 31, 2025 | 32,899.92 |
| Sep 30, 2025 | -2,192.98 |
| Sep 30, 2025 | -2,192.98 |
| Jun 30, 2025 | -4,647.11 |
| Jun 30, 2025 | -4,647.11 |
| Mar 31, 2025 | -8,320.49 |
| Mar 31, 2025 | -8,320.49 |
| Dec 31, 2024 | 26,071.94 |
| Dec 31, 2024 | 26,071.94 |
| Sep 30, 2024 | -5,769.86 |
| Sep 30, 2024 | -5,769.86 |
| Jun 30, 2024 | -2,778.33 |
| Jun 30, 2024 | -2,778.33 |
| Mar 31, 2024 | -2,567.71 |
| Mar 31, 2024 | -2,567.71 |
| Dec 31, 2023 | 86,614.96 |
| Dec 31, 2023 | 86,614.96 |